In gastrointestinal tumors with predominantly KLF5 amplification, including gastric cancer (STAD), colon cancer (COAD), and rectum cancer (READ), an increase in KLF5 transcripts could be observed (Figure 2, top 3). This evidence concerns the gene KLF5 and malignant colon neoplasm.